CARDENE

This brand name is authorized in Netherlands, United Kingdom, United States

Active ingredients

The drug CARDENE contains one active pharmaceutical ingredient (API):

1 Nicardipine UNII K5BC5011K3 - NICARDIPINE HYDROCHLORIDE

Nicardipine is a second generation slow calcium channel inhibitor, and belongs to the phenyl-dihydropyridine group. Nicardipine has a greater selectivity for L-type calcium channels in vascular smooth muscle than cardiac myocytes. Nicardipine produces smooth muscle relaxation and marked peripheral vasodilatation. Read about Nicardipine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CARDENE IV Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR
CARDENE Hard capsule	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C08CA04	Nicardipine	C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 14958, 15021
Country: NL	Z-Index G-Standaard	Identifier(s): 14180375
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 36765
Country: US	FDA, National Drug Code	Identifier(s): 10122-313, 10122-314, 10122-325, 43066-016